Tsiagbe V K, Rabinowitz J L, Thorbecke G J
Department of Pathology, New York University School of Medicine, New York 10016.
Cell Immunol. 1991 Sep;136(2):329-39. doi: 10.1016/0008-8749(91)90356-g.
The nature of the antigen on SJL lymphoma (reticulum cell sarcomas, RCS) cells that is strongly stimulatory to syngeneic CD4+ T cells is still elusive. Previously, we showed that the response to RCS of T cells from F1 hybrids of SJL by strains expressing I-Ak,d and/or I-Ek,d was much lower than that of T cells from SJL mice or from F1 hybrids of SJL by H2b- or H2s-bearing strains. We now show that removal of CD8+T cells from the responding cell population of (SJL x BALB/c)F1 or (SJL x A.TL)F1 mice does not enhance their responses, suggesting that the negative effect of H2k,d is not due to suppressor cells. Moreover, repeated injections of RCS cells into such F1 mice also fail to enhance the response, suggesting that these mice lack responder cells. T cells from I-E alpha transgenic (C57BL x SJL)F1 mice backcrossed to SJL respond to RCS as do T cells from I-E alpha- littermates or SJL mice. Similarly, I-E alpha+ SJL mice support RCS growth in vivo to the same (LN + spleen)/body weight ratio as do I-E- littermates. Thus, while I-E appears to have a negative influence on T cell responsiveness and RCS growth in F1 mice, it does not have such an effect when present, by itself, on a SJL background. The role of V beta 17 a+ T cells in the response of SJL T cells to RCS was also examined, because such cells are known to be responsive to I-E. The responses of V beta 17a(+)-depleted (0.3% V beta 17 a+) and V beta 17 a(+)-enriched (25.3% V beta 17a+) SJL T cell populations to RCS were examined by limiting dilution. We found the incidence of responding cells to be slightly higher in the depleted (0.016%) than in the (0.006%) enriched population. Furthermore, lymph node blast cell populations responding to RCS do not exhibit a higher percentage of cells staining for V beta 17a than do blast cells responding to Con A or unstimulated lymph node cells.
对同基因CD4+T细胞具有强烈刺激作用的SJL淋巴瘤(网状细胞肉瘤,RCS)细胞上的抗原性质仍然不清楚。以前,我们发现,表达I-Ak,d和/或I-Ek,d的品系与SJL的F1杂种来源的T细胞对RCS的反应比SJL小鼠或携带H2b或H2s的品系与SJL的F1杂种来源的T细胞的反应低得多。我们现在发现,从(SJL×BALB/c)F1或(SJL×A.TL)F1小鼠的反应细胞群体中去除CD8+T细胞并不能增强它们的反应,这表明H2k,d的负面影响不是由于抑制细胞。此外,向此类F1小鼠反复注射RCS细胞也不能增强反应,这表明这些小鼠缺乏反应细胞。回交至SJL的I-Eα转基因(C57BL×SJL)F1小鼠来源的T细胞对RCS的反应与I-Eα同窝小鼠或SJL小鼠来源的T细胞相同。同样,I-Eα+SJL小鼠在体内支持RCS生长的(淋巴结+脾脏)/体重比与I-E-同窝小鼠相同。因此,虽然I-E似乎对F1小鼠的T细胞反应性和RCS生长有负面影响,但当它本身存在于SJL背景中时则没有这种作用。还研究了Vβ17a+T细胞在SJL T细胞对RCS反应中的作用,因为已知此类细胞对I-E有反应。通过有限稀释法检测了Vβ17a耗竭(0.3%Vβ17a+)和Vβ17a富集(25.3%Vβ17a+)的SJL T细胞群体对RCS的反应。我们发现,耗竭群体(0.016%)中反应细胞的发生率略高于富集群体(0.006%)。此外, 对RCS有反应的淋巴结母细胞群体中,与对伴刀豆球蛋白A有反应的母细胞或未受刺激的淋巴结细胞相比,Vβ17a染色的细胞百分比并不更高。